COG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.123400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.708560E-01
Normal-vs-Stage2
6.330600E-01
Normal-vs-Stage3
1.725820E-01
Normal-vs-Stage4
2.568600E-01
Stage1-vs-Stage2
1.228330E-02
Stage1-vs-Stage3
2.752300E-02
Stage1-vs-Stage4
4.460000E-01
Stage2-vs-Stage3
4.035700E-02
Stage2-vs-Stage4
3.988200E-01
Stage3-vs-Stage4
3.469800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.758000E-01
Normal-vs-AfricanAmerican
5.705700E-02
Normal-vs-Asian
3.132400E-01
Caucasian-vs-AfricanAmerican
1.531960E-01
Caucasian-vs-Asian
1.370760E-01
AfricanAmerican-vs-Asian
8.080800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.624200E-01
Normal-vs-Female
6.904600E-01
Male-vs-Female
4.097600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.524200E-01
Normal-vs-Age(41-60Yrs)
6.480200E-01
Normal-vs-Age(61-80Yrs)
6.424200E-01
Normal-vs-Age(81-100Yrs)
4.729000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.109000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.592400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.675200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.197200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.324600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.908600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.105000E-01
Normal-vs-Daily Drinker
8.144600E-01
Normal-vs-Weekly Drinker
7.147400E-01
Normal-vs-Occasional Drinker
3.621800E-01
Normal-vs-Social Drinker
5.187800E-01
Non Drinker-vs-Daily Drinker
2.040800E-01
Non Drinker-vs-Weekly Drinker
8.589400E-01
Non Drinker-vs-Occasional Drinker
4.069600E-01
Non Drinker-vs-Social Drinker
6.024200E-01
Daily Drinker-vs-Weekly Drinker
2.591200E-01
Daily Drinker-vs-Occasional Drinker
3.482100E-02
Daily Drinker-vs-Social Drinker
1.004760E-01
Weekly Drinker-vs-Occasional Drinker
6.486400E-01
Weekly Drinker-vs-Social Drinker
8.106400E-01
Occasional Drinker-vs-Social Drinker
8.261600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.933920E-02
Normal-vs-Grade 2
3.004800E-03
Normal-vs-Grade 3
6.581000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.573000E-01
Grade 1-vs-Grade 3
9.206800E-01
Grade 1-vs-Grade 4
1.933920E-02
Grade 2-vs-Grade 3
5.736200E-01
Grade 2-vs-Grade 4
3.004800E-03
Grade 3-vs-Grade 4
6.581000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.596200E-01
Normal-vs-NonDiabetic
5.609200E-01
Diabetic-vs-NonDiabetic
5.040400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.870400E-01
Normal-vs-NoPancreatitis
6.564200E-01
Pancreatitis-vs-NoPancreatitis
5.014600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.966000E-01
Normal-vs-N1
7.363800E-01
N0-vs-N1
2.622000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.331600E-01
Normal-vs-TP53-NonMutant
2.950600E-01
TP53-Mutant-vs-TP53-NonMutant
6.027800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
